Skip to main content

Table 3 Molecular subtypes, tumor characteristics and PET findings

From: Correlation between tumor to liver SUV ratio and molecular subtypes of invasive breast carcinoma in PET CT

  Luminal A Luminal B Triple negative HER2/Neu
Number of the patients 11 (44%) 5 (20%) 3 (12%) 6 (24%)
Age 52.09 ± 14.88 51.60 ± 13.54 53.33 ± 6.66 57.17 ± 10.80
Range: 29–79 Range: 29–63 Range: 46–59 Range: 43–75
Histological type of the carcinoma Invasive ductal: 8 (72.7%) Invasive ductal: 4 (80%) Invasive ductal: 3 (100%) Invasive ductal: 6 (100%)
Invasive lobular: 3 (27.3%) Invasive lobular: 1 (20%) Invasive lobular: 0 (0%) Invasive lobular: 0 (0%)
Grade I: 0 (0%) I: 1 (20%) I: 0 (0%) I: 0 (0%)
II: 8 (72.7%) II: 2 (40%) II: 2 (66.7%) II: 3 (50%)
III: 3 (27.3%) III: 2 (40%) III: 1 (33.3%) III: 3 (50%)
LN Positive: 9 (81.8%) Positive: 3 (60%) Positive: 2 (66.7%) Positive: 6 (100%)
Negative: 2 (18.2%) Negative: 2 (40%) Negative: 1 (33.3%) Negative: 0 (0%)
Metastasis Positive: 5 (45.5%) Positive: 0 (0%) Positive: 2 (66.7%) Positive: 2 (33.3%)
Negative: 6 (54.5%) Negative: 5 (100%) Negative: 1 (33.3%) Negative: 4 (66.7%)
Ki67 33.27 ± 18.14 27.4 ± 8.88 30 ± 7 34.17 ± 9.33
Range: 20–85 Range: 12–35 Range: 25–38 Range: 25–50
Liver SUVmax 2.08 ± 0.73 2.06 ± 0.40 1.67 ± 0.15 2.27 ± 0.70
Range: 1.2–3.8 Range: 1.5–2.5 Range: 1.5–1.8 Range: 1.3–2.9
Spleen SUVmax 1.78 ± 0.54 1.92 ± 0.66 1.47 ± 0.15 2.27 ± 0.82
Range: 1–1.3 Range: 1.1–2.9 Range: 1.3–1.6 Range: 1.2–3.1